By: Benzinga
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE
Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX ) is 18.99%. Akorn's revenue for the same period is $227.26 million. The trailing-twelve-month return on equity at Hi Tech Pharmacal Co (NASDAQ: HITK ) is
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here